We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Health Care Workers Carry Diarrhea Spores on Their Hands

By LabMedica International staff writers
Posted on 23 Jan 2014
It is not uncommon to find the bacteria Clostridium difficile on the hands of health care workers, highlighting a possible route through which the diarrhea causing bacteria spreads in hospitals.

There is a view that many health care workers could be passing on C. More...
difficile to patients, even after routine alcohol-based hand rubbing, pointing to a need for routine hand washing with soap and water after treating any infected patient, regardless of the setting.

Scientists from the Geneva University Hospitals (Switzerland) and their colleagues compared hand contamination of health care workers caring for patients infected with C. difficile with that of workers caring for non-infected patient. The prospective study was performed from June through August 2007 in a 950-bed French university hospital, at a time when the overall incidence of C. difficile infection (CDI) was 1.3 cases per 10,000 bed-days, with 68% of cases classified as hospital acquired.

The sampling of the health care workers (HCW) hands was performed using a method of spore salvage developed by the scientists. Colonies of C. difficile were initially identified by their macroscopic appearance and odor, followed by latex agglutination testing (Oxoid C. difficile Test kit, Thermo Scientific; Basingstoke, UK). During the study observation period, 7 CDI case patients and 16 control patients were included and were cared for by 66 exposed and 44 unexposed HCWs, respectively. All 110 HCWs had their hands sampled. The majority of participating HCWs were nurses and nursing assistants.

C. difficile spores were recovered from 24% (16/66) samples obtained from hands of exposed HCWs and from none (0/44) of those obtained from unexposed HCWs. A mean of two colony-forming units (CFUs) (range, one to six) of C. difficile were recovered per positive hand, with the highest numbers found following high-risk care. Contamination occurred with high-risk contact, for instance, when the health care worker did not wear gloves, or when they washed patients after fecal soiling, or following a digital rectal exam, changing soiled bed linen, or carrying out a colonoscopy. Hand contamination was also linked to duration of high-risk contact and was more common among nursing assistants whose contamination rate was 42%, than other workers such as physicians with a contamination rate of 23%, and nurses at 19%.

The authors concluded that nearly one-quarter of HCWs have hands contaminated with C. difficile spores after routine care of patients with CDI. Hand contamination is positively associated with exposure to fecal soiling and lack of glove use. Caroline Landelle, PharmD, PhD, the lead author of the study said, “Because C. difficile spores are so resistant and persistent to disinfection, glove use is not an absolute barrier against the contamination of health care workers' hands. Effective hand hygiene should be performed, even in nonoutbreak settings.” The study was published on November 26, 2013, in the journal Infection Control and Hospital Epidemiology.

Related Links:

Geneva University Hospitals 
Oxoid



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.